Literature DB >> 25570858

Multi-level gene/MiRNA feature selection using deep belief nets and active learning.

Rania Ibrahim, Noha A Yousri, Mohamed A Ismail, Nagwa M El-Makky.   

Abstract

Selecting the most discriminative genes/miRNAs has been raised as an important task in bioinformatics to enhance disease classifiers and to mitigate the dimensionality curse problem. Original feature selection methods choose genes/miRNAs based on their individual features regardless of how they perform together. Considering group features instead of individual ones provides a better view for selecting the most informative genes/miRNAs. Recently, deep learning has proven its ability in representing the data in multiple levels of abstraction, allowing for better discrimination between different classes. However, the idea of using deep learning for feature selection is not widely used in the bioinformatics field yet. In this paper, a novel multi-level feature selection approach named MLFS is proposed for selecting genes/miRNAs based on expression profiles. The approach is based on both deep and active learning. Moreover, an extension to use the technique for miRNAs is presented by considering the biological relation between miRNAs and genes. Experimental results show that the approach was able to outperform classical feature selection methods in hepatocellular carcinoma (HCC) by 9%, lung cancer by 6% and breast cancer by around 10% in F1-measure. Results also show the enhancement in F1-measure of our approach over recently related work in [1] and [2].

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25570858     DOI: 10.1109/EMBC.2014.6944490

Source DB:  PubMed          Journal:  Conf Proc IEEE Eng Med Biol Soc        ISSN: 1557-170X


  9 in total

Review 1.  Progress in Biomedical Knowledge Discovery: A 25-year Retrospective.

Authors:  L Sacchi; J H Holmes
Journal:  Yearb Med Inform       Date:  2016-08-02

Review 2.  Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.

Authors:  Wei Wang; Raju Kandimalla; Hao Huang; Lina Zhu; Ying Li; Feng Gao; Ajay Goel; Xin Wang
Journal:  Semin Cancer Biol       Date:  2018-05-18       Impact factor: 15.707

3.  Effective Cancer Subtype and Stage Prediction via Dropfeature-DNNs.

Authors:  Zhong Chen; Wensheng Zhang; Hongwen Deng; Kun Zhang
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2022-02-03       Impact factor: 3.710

4.  Discrimination of Breast Cancer with Microcalcifications on Mammography by Deep Learning.

Authors:  Jinhua Wang; Xi Yang; Hongmin Cai; Wanchang Tan; Cangzheng Jin; Li Li
Journal:  Sci Rep       Date:  2016-06-07       Impact factor: 4.379

5.  In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development.

Authors:  Ivan V Ozerov; Ksenia V Lezhnina; Evgeny Izumchenko; Artem V Artemov; Sergey Medintsev; Quentin Vanhaelen; Alexander Aliper; Jan Vijg; Andreyan N Osipov; Ivan Labat; Michael D West; Anton Buzdin; Charles R Cantor; Yuri Nikolsky; Nikolay Borisov; Irina Irincheeva; Edward Khokhlovich; David Sidransky; Miguel Luiz Camargo; Alex Zhavoronkov
Journal:  Nat Commun       Date:  2016-11-16       Impact factor: 14.919

6.  Cancer Characteristic Gene Selection via Sample Learning Based on Deep Sparse Filtering.

Authors:  Jian Liu; Yuhu Cheng; Xuesong Wang; Lin Zhang; Z Jane Wang
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

Review 7.  Deep Learning in Mining Biological Data.

Authors:  Mufti Mahmud; M Shamim Kaiser; T Martin McGinnity; Amir Hussain
Journal:  Cognit Comput       Date:  2021-01-05       Impact factor: 5.418

8.  Colorectal cancer subtype identification from differential gene expression levels using minimalist deep learning.

Authors:  Shaochuan Li; Yuning Yang; Xin Wang; Jun Li; Jun Yu; Xiangtao Li; Ka-Chun Wong
Journal:  BioData Min       Date:  2022-04-23       Impact factor: 4.079

9.  Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data.

Authors:  Alexander Aliper; Sergey Plis; Artem Artemov; Alvaro Ulloa; Polina Mamoshina; Alex Zhavoronkov
Journal:  Mol Pharm       Date:  2016-06-08       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.